Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adrenocortical Cancer
Research conducted at University of Sydney has provided new information about adrenocortical cancer
March 23rd, 2008
"Laparoscopic adrenalectomy has surpassed open adrenalectomy as the gold standard for excision of benign adrenal lesions. The size threshold for offering laparoscopic adrenalectomy is controversial as the prevalence of adrenocortical carcinoma increases with increasing tumour size," researchers in Australia report. "The aim of this paper was to assess the safety of laparoscopoic adrenalectomy for large adrenal tumours (tumours >= 60 mm). A retrospective cohort study of patients who underwent adrenalectomy in a single unit during the period 1995-2005 was undertaken. One hundred and seventy patients with 173 tumours were included in this study. Of these, 29 were >=...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-23)
|
